Effects on pancreatic Beta and other Islet cells of the glucose-dependent insulinotropic polypeptide. (2020)
Attributed to:
Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetes
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.peptides.2019.170201
PubMed Identifier: 31751656
Publication URI: http://europepmc.org/abstract/MED/31751656
Type: Journal Article/Review
Volume: 125
Parent Publication: Peptides
ISSN: 0196-9781